JS
Jignesh Sureshbhai Shah
About Jignesh Sureshbhai Shah
Jignesh Sureshbhai Shah has 8 years in corporate governance. Holds Designated Partner and Director roles. Currently with 6 companies, including Synetech Lifescience Llp and Synetech Pharma Drugs Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Synetech Lifescience Llp
AAW-0534
|
Designated Partner | 25 Feb 2021 | 2021 | Active |
|
Synetech Pharma Drugs Private Limited
U24100GJ2020PTC113199
|
Director | 05 Mar 2021 | 2020 | Active |
|
Synex Global Alliance Llp
AAO-5312
|
Designated Partner | 13 Mar 2019 | 2019 | Active |
Synex Global Services Llp
AAK-8738
|
Designated Partner | 16 Oct 2017 | 2017 | Active |
|
Synex Global Enterprises Llp
ACT-0728
|
Designated Partner | 28 Nov 2025 | 2025 | Active |
|
German Freight Terminal Llp
ACF-4807
|
Designated Partner | 11 Feb 2024 | 2024 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jignesh Sureshbhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jignesh Sureshbhai Shah
Jignesh Sureshbhai Shah has 8 years in corporate governance. Holds Designated Partner and Director roles. Currently with 6 companies, including Synetech Lifescience Llp and Synetech Pharma Drugs Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Jignesh Sureshbhai Shah is associated with 6 companies as Designated Partner and Director.
Jignesh Sureshbhai Shah has expertise in Technology, General Business.
Jignesh Sureshbhai Shah has 8 years in corporate governance.